Overview of the latest issue of Angewandte Chemie

Antibody levels indicate need for two vaccine doses in those not infected before, single dose for those with past COVID-19, and booster shots for everybody

Combination of AstraZeneca vaccine as first dose and BioNTech/Pfizer vaccine as second dose could be beneficial, according to preprint

Eight-step preparation starting from 4-N-benzoylcytidine

Prochelators bind to serum albumin to form anti-cancer bioconjugates

Evonik and Stanford University enter into research collaboration

Shows 90 % overall efficacy and 100 % protection against moderate and severe disease in Phase 3 study, according to manufacturer

Highlights from Chemistry Europe, ACES, and GDCh journals

Biodegradable membrane composed of protein nanofibrils and iron oxyhydroxide nanoparticles                     

Cleavage of host proteins by viral proteases could be related to COVID-19 symptoms